ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Baltimore, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Breast Cancer
Ovarian Cancer
Endometrial Cancer
Neoplasm Metastasis
Non-Small-Cell Lung Carcinoma

Prostate Cancer trials near Baltimore, MD, USA:

WATER IV Prostate Cancer (WATER IV PCa)

Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, pros...

Enrolling
Localized Prostate Cancer
Device: Aquablation Therapy
Procedure: Radical Prostatectomy
PROCEPT BioRobotics

Baltimore, Maryland, United States and 38 other locations

Asymptomatic patients with metastatic castrate resistant prostate cancer (mCRPC) without pain due to prostate cancer...

Enrolling
Prostate Cancer
Drug: Enzalutamide
Drug: Luteinizing hormone-releasing hormone (LHRH) analogue

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Baltimore, Maryland, United States

The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...

Active, not recruiting
Prostate Cancer
Biological: placebo
Drug: valacyclovir

Phase 2

Candel Therapeutics

Bethesda, Maryland, United States and 22 other locations

The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate...

Active, not recruiting
Benign Prostatic Hyperplasia
Localized Prostate Cancer
Device: Robotic Waterjet Treatment
PROCEPT BioRobotics

Alexandria, Virginia, United States and 5 other locations

pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007
Drug: Darolutamide

Phase 1

Janux Therapeutics

Baltimore, Maryland, United States and 34 other locations

A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-766 + Abiraterone Part C&D
Drug: ARV-766 Part A&B

Phase 1, Phase 2

Novartis
Novartis

Baltimore, Maryland, United States and 22 other locations

Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potentia ...

Enrolling
Metastatic Castration Resistant Prostate Cancer
Metastatic Castration-sensitive Prostate Cancer
Drug: prednisone
Drug: PRL-02 injection

Phase 1

Astellas
Astellas

Towson, Maryland, United States and 24 other locations

This study evaluates the efficacy, anti-tumor effect, and immunogenicity of neoadjuvant enoblituzumab given before radical prostatectomy. Pa...

Enrolling
Prostate Cancer
Drug: Enoblituzumab
Other: Standard of Care

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Baltimore, Maryland, United States and 4 other locations

The overall aim of the trial is to evaluate the safety, tolerability, and pharmacokinetics (PK) of AMG 509 (monotherapy and in combination with abira...

Enrolling
Prostate Cancer
Drug: AMG 509
Drug: Abiraterone

Phase 1

Amgen
Amgen

Fairfax, Virginia, United States and 55 other locations

The primary objective of this study is to compare the progression free survival (PFS) of patients with metastatic castration-resistant prostate...

Active, not recruiting
Prostate Cancer
Drug: LY2157299
Drug: Enzalutamide

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Baltimore, Maryland, United States and 3 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems